Patricia Zilliox

Patricia brings more than 25 years of expertise in global clinical development in ophthalmology. During her 30-plus–year career at Alcon Laboratories, Patricia managed clinical development programs in areas of eye disease such as glaucoma, allergy, dry eye, infectious eye diseases, and retinal diseases, including dry and wet age-related macular degeneration. At Alcon in Paris, France, she was responsible for the execution of Alcon’s European ophthalmology clinical trials. Most recently, Patricia served as chief drug development officer of the Clinical Research Institute, a division of the Foundation Fighting Blindness, in Columbia, Maryland.